Company

Flamingo Pharma UK Ltd

Pharmaceutical intelligence for Flamingo Pharma UK Ltd with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 1
Catalysts: 1
Assets: 2

Recent signals(1)

RegulatoryJuly 2, 2026

Flamingo Pharma recalls Flucloxacillin Capsules due to incorrect patient information leaflet

Flamingo Pharma UK Ltd has recalled certain packs of Flucloxacillin Capsules BP 500mg due to containing the incorrect patient information leaflet for Amoxicillin.

Upcoming catalysts

No catalysts indexed for this entity yet.

Regulatory activity(1)

RegulatoryJuly 2, 2026

Flamingo Pharma recalls Flucloxacillin Capsules due to incorrect patient information leaflet

Flamingo Pharma UK Ltd has recalled certain packs of Flucloxacillin Capsules BP 500mg due to containing the incorrect patient information leaflet for Amoxicillin.

Clinical activity

No signals indexed for this entity yet.

Competitive activity

No signals indexed for this entity yet.

Assets

Flamingo →

Safety Signal →

Therapeutic areas

Antibiotic →

Infectious Disease →

Infectious Disease · Antibiotic →

Indications

Infectious Disease →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.